Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Tag Archives: march-in
The failed Bayh-Dole bargain, 3
We are working through a new article on Bayh-Dole march-in, written by two PhD patent attorneys. In its way, the article is more puff piece than law review, drawing its frame from the sources chosen, not much looking at the … Continue reading
The failed Bayh-Dole bargain, 1
Dr. Rebecca McFadyen and Dr. Tara Nealey–both working for an IP law firm–have published an article “Will old Bayh-Dole be taught new tricks?” Me, Dr. Barnett–not working for an IP law firm–thinks they have got it wrong. Consider: Before 1980 … Continue reading
Bayh-Dole, Competition, Reasonable Terms, and March-in (Short Version)
How are competition, reasonable terms, and march-in related in Bayh-Dole? Here is the short version. Bayh-Dole stipulates that a contractor must timely achieve practical application of a subject invention and must reasonably satisfy public health needs in doing so. 35 … Continue reading
Posted in Bayh-Dole
Tagged antitrust, Bayh-Dole, competition, cry, march-in, reasonable terms
Comments Off on Bayh-Dole, Competition, Reasonable Terms, and March-in (Short Version)
Bayh-Dole is a competition and technology transfer statute
The Bayh-Dole Coalition, a lobbying front for pharma and university patent administrators, claims that Bayh-Dole is a “tech transfer statute” that would be misused if federal agencies used its march-in provisions to address drug pricing. If companies cannot price-gouge, they … Continue reading
Posted in Bayh-Dole, Technology Transfer
Tagged Bayh-Dole, competition, government license, march-in
Comments Off on Bayh-Dole is a competition and technology transfer statute
Making Bayh-Dole March-in and Government License Work
There’s a lot of stirrings about using Bayh-Dole’s march-in procedure to address the high price of drugs in the United States. Under march-in, a federal agency has the right to require a federal contractor (or anyone who is an assignee … Continue reading
Posted in Bayh-Dole
Tagged Bayh-Dole, march-in, practice and have practiced
Comments Off on Making Bayh-Dole March-in and Government License Work
Unenforced, Bayh-Dole enables a federal offer to look the other way on price-gouging
The government’s failure to use its government license to practice and have practiced (=make, use, and sell) puts undue pressure on march-in to address nonuse and unreasonable use of inventions arising in work receiving federal support. NIST wants to gut … Continue reading
Posted in Bayh-Dole, high priced medicines, History, Vannever Bush
Tagged Bayh-Dole, government license, march-in, monopoly pricing, NIST
Comments Off on Unenforced, Bayh-Dole enables a federal offer to look the other way on price-gouging
proto Bayh-Dole march-in, c. 1976
Bayh-Dole was the banana that finally stuck on wall, but Norman Latker had tried any number of schemes to circumvent federal policy requiring default open access to the inventions arising in work for which the federal government provided funding. People … Continue reading
Reflections on Shill Reflections on Bayh-Dole, 7: Grubbers, innovation, and march-in
Reflections on Bayh-Dole by “industry leaders”–who are, apparently, mostly shills out shilling for (and to) the pharmaceutical industry. Good shilling earns shillings, so it is a viable career choice. We use these shills reflecting on Bayh-Dole to also reflect on … Continue reading
The Wall Street Journal publishes an editorial against using Bayh-Dole march-in for remdesivir
Sally Pipes has published an op/ed piece at the Wall Street Journal on Bayh-Dole and Gilead, “The Remdesivir Patent Isn’t State Property.” There is so much going on with Pipes’s work. We should take a closer look. First, the title … Continue reading
Posted in Bayh-Dole, high priced medicines, Policy
Tagged Bayh-Dole, ludicrous, march-in, remdesivir
Comments Off on The Wall Street Journal publishes an editorial against using Bayh-Dole march-in for remdesivir
Defense Contracting, Bayh-Dole Fantasies, and Workarounds–3
We have been working through a DoD guide for contracting officers in navigating IP rights–Bayh-Dole and data rights. The data rights are a whole nother saga, so we are leaving them alone for now. Here in summary form are the … Continue reading
Posted in Bayh-Dole
Tagged Bayh-Dole, manufactured substantially, march-in, trade secret
Comments Off on Defense Contracting, Bayh-Dole Fantasies, and Workarounds–3